Global Subcutaneous Immunotherapy Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Subcutaneous Immunotherapy market size will reach US$ million by 2031.
Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.
United States market for Subcutaneous Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Subcutaneous Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Subcutaneous Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Subcutaneous Immunotherapy players cover Anergis, HAL Allergy Group, Merck, Allergy Therapeutics, ALK-Abello, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Subcutaneous Immunotherapy Industry Forecast” looks at past sales and reviews total world Subcutaneous Immunotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Subcutaneous Immunotherapy sales for 2025 through 2031. With Subcutaneous Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subcutaneous Immunotherapy industry.
This Insight Report provides a comprehensive analysis of the global Subcutaneous Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Subcutaneous Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Subcutaneous Immunotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subcutaneous Immunotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subcutaneous Immunotherapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Asthma
Allergic Rhinitis
Venom Allergy
Food Allergy
Segmentation by Application:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Anergis
HAL Allergy Group
Merck
Allergy Therapeutics
ALK-Abello
Stallergenes Greer
Laboratorios LETI
Please note: The report will take approximately 2 business days to prepare and deliver.
Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.
United States market for Subcutaneous Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Subcutaneous Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Subcutaneous Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Subcutaneous Immunotherapy players cover Anergis, HAL Allergy Group, Merck, Allergy Therapeutics, ALK-Abello, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Subcutaneous Immunotherapy Industry Forecast” looks at past sales and reviews total world Subcutaneous Immunotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Subcutaneous Immunotherapy sales for 2025 through 2031. With Subcutaneous Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subcutaneous Immunotherapy industry.
This Insight Report provides a comprehensive analysis of the global Subcutaneous Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Subcutaneous Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Subcutaneous Immunotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subcutaneous Immunotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subcutaneous Immunotherapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Asthma
Allergic Rhinitis
Venom Allergy
Food Allergy
Segmentation by Application:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Anergis
HAL Allergy Group
Merck
Allergy Therapeutics
ALK-Abello
Stallergenes Greer
Laboratorios LETI
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
87 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Subcutaneous Immunotherapy Market Size by Player
- 4 Subcutaneous Immunotherapy by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Subcutaneous Immunotherapy Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
